NASDAQ · RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
Healthcare · Biotechnology
$3.55
Up+$0.02 (+0.42%)
Updated Nov 11, 2026, 3:04 PM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.83B
- P/E ratio
- -2.94
- Dividend yield
- 0.00%
- 52-week range
- $2.77 – $5.24
- Volume
- 19.1M
- Avg. volume
- 43.4M
Price performance · RXRX
RXRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 10, 2026
RXRX closed at $3.55 after 21 trading sessions, down 7.43% for the selected period.
- Last close
- $3.55
- Period change
- -7.43%
- Period low
- $3.47
- Period high
- $4.35
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 10, 2026 | $3.69 | $3.77 | $3.47 | $3.55 | 19.1M |
| Nov 9, 2026 | $3.52 | $3.87 | $3.4701 | $3.805 | 20.37M |
| Nov 6, 2026 | $3.585 | $3.645 | $3.48 | $3.52 | 15.59M |
| Nov 5, 2026 | $3.79 | $3.795 | $3.42 | $3.50 | 25.42M |
| Nov 4, 2026 | $3.83 | $4.01 | $3.72 | $3.88 | 20.59M |
| Nov 3, 2026 | $3.855 | $4.08 | $3.65 | $3.68 | 20.78M |
| Nov 2, 2026 | $4.11 | $4.17 | $3.78 | $3.83 | 22.57M |
| Oct 30, 2026 | $4.05 | $4.1595 | $3.7847 | $4.03 | 24.41M |
| Oct 29, 2026 | $4.25 | $4.515 | $4.15 | $4.24 | 20.96M |
| Oct 28, 2026 | $4.00 | $4.43 | $3.9927 | $4.35 | 28.5M |
| Oct 27, 2026 | $3.81 | $4.145 | $3.7301 | $4.05 | 22.17M |
| Oct 26, 2026 | $3.71 | $3.86 | $3.64 | $3.80 | 16.1M |
| Oct 23, 2026 | $3.52 | $3.70 | $3.45 | $3.70 | 19.08M |
| Oct 22, 2026 | $3.54 | $3.68 | $3.485 | $3.58 | 17.74M |
| Oct 21, 2026 | $3.66 | $3.76 | $3.56 | $3.64 | 19.36M |
| Oct 20, 2026 | $3.555 | $3.67 | $3.47 | $3.66 | 20.93M |
| Oct 19, 2026 | $3.53 | $3.69 | $3.48 | $3.61 | 30.01M |
| Oct 16, 2026 | $4.11 | $4.185 | $3.44 | $3.465 | 40.72M |
| Oct 15, 2026 | $3.65 | $4.41 | $3.53 | $4.16 | 62.87M |
| Oct 14, 2026 | $3.72 | $3.91 | $3.66 | $3.74 | 18.78M |
| Oct 13, 2026 | $4.01 | $4.05 | $3.82 | $3.835 | 19.76M |
Latest RXRX news
The latest Smart Investors Daily articles mentioning RXRX.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News

